Gout

Disease ID:1027
Name:Gout
Associated with:1 target
3 immuno-relevant ligands
Database Links
Disease Ontology: DOID:13189

Targets

NLRP3

Ligands

Key to terms and symbols Click ligand name to view ligand summary Click column headers to sort
Ligand References Clinical and Disease comments
etoricoxib
Immuno Disease Comments: Selective COX2 inhibitor approved for the treatment of many inflammatory conditions including gout.
Clinical Use: Used in the treatment of rheumatoid arthritis, osteoarthritis, chronic lower back pain, ankylosing spondylitis, acute pain and gout. There is no information regarding approval for medicinal use of etoricoxib on the US FDA website. Individual national agencies may have granted marketing approval. | View clinical data
naproxen
Immuno Disease Comments: Approved NSAID used for acute gout.
Clinical Use: Used in the treatment of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, tendinitis, bursitis, and acute gout. Also used in pain relief in the treatment of primary dysmenorrhea. | View clinical data
sulindac
Immuno Disease Comments: Approved drug for gout.
Clinical Use: For acute relief or long term use in osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, acute painful shoulder and acute gouty arthritis. | View clinical data
Bioactivity Comments: We have been unable to find affinity data for this drug to substantiate its MMOA | View biological activity